Merck & Co., Inc. (NYSE:MRK) In $14 Billion Asset Sale Talks With Bayer AG

Boston, MA 05/02/2014 (wallstreetpr) – Merck & Co., Inc. (NYSE:MRK) is reported to be in exclusive asset sale talks with the German pharmaceutical giant Bayer AG, according to the people with insider knowledge. Talks with Bayer for the sale of Merck’s over-the-counter business comes on the back of a withdrawal of one of the front bidders. […]

Who Wants To Buy Sanofi SA (ADR) (NYSE:SNY)’s Older Drugs Division?

Boston, MA 05/01/2014 (wallstreetpr) – Sanofi SA (ADR) (NYSE:SNY) is on the verge of selling its older drugs portfolio. The portfolio is reported to be made up of drugs targeted at the treatment of cardio-metabolic conditions and high blood pressure. The drug portfolio fetches about $3.7 billion in annual revenue, according to people with insider knowledge. […]

Sanofi SA (ADR) (NYSE:SNY) Q1 Results In Line With FY Target

Boston, MA 04/30/2014 (wallstreetpr) – Drug maker Sanofi SA (ADR) (NYSE:SNY) delivered first quarter results that is in line with the full year targets set by itself. The company’s diabetes and consumer healthcare divisions produced double-digit growth even as the net sales grew 3.5% on an adjusted basis.  The company’s bottom line, on a non-GAAP basis, […]

Sanofi SA (ADR) (NYSE:SNY) Prefers Small Deals Over Mega Acquisitions

Boston, MA 04/29/2014 (wallstreetpr) – On Tuesday, Sanofi SA (ADR) (NYSE:SNY)‘s Chief Executive Officer, Christopher Viehbacher, reiterated that the French drug maker will continue to concentrate on its targeted smaller acquisitions, even as the pharmaceutical sector is hitting several megadeals. Focus On Growth Areas The comment of Mr. Viehbacher comes at a time when a day […]

Sanofi SA (ADR) (NYSE:SNY) And AstraZeneca Plc (ADR) (NYSE:AZN) Echo Same Tone

Boston, MA 02/06/2014 (wallstreetpr) – Sanofi SA (ADR) (NYSE:SNY), the healthcare provider based in France, reported fourth quarter profits in line with the projections. Although sales were lower on the back of the weaker currency scenario in the emerging markets. Sanofi’s Fourth Quarter Overview Sanofi SA (ADR) (NYSE:SNY)‘s net income for the complete year, excluding charges, […]

Pfizer Inc (NYSE:PFE) Among The Ten To Collaborate With The U.S. Government In Combating America’s Most Prevalent Diseases

Boston, MA 02/06/2014 (wallstreetpr) – Pfizer Inc (NYSE:PFE) is to work with the U.S. government to develop new treatments for some of the most prevalent diseases among Americans. In a $230 million project the government is trying to identify new cure for Alzheimer’s, diabetes, lupus and arthritis. In accordance with the practice of ‘groundbreaking’ at […]

Stock Update: Alpha Natural Resources (NYSE:ANR); Johnson & Johnson (NYSE:JNJ) And Suncor Energy Inc. (USA) (NYSE:SU)

Boston, MA 02/05/2014 (wallstreetpr) – Alpha Natural Resources (NYSE:ANR), declared in a press release that four of its associateoperations have been admiredfor protecting the environment. Alpha has received the honors from two departments namely, West Virginia Department of Environmental Protection and the other being West Virginia Coal Association for its exceptional contribution towards reclamation, reforestation […]

Dassault Systemes S.A. (EPA:DSY) To Take Over Accelrys Inc (NASDAQ:ACCL) in $750 Million Cash Deal

Boston, MA 01/31/2014 (wallstreetpr) – Accelrys Inc (NASDAQ:ACCL) is to be acquired by Dassault Systemes S.A. (EPA:DSY) in an all cash deal of $750 million. The French maker of 3-dimensioanl design software has agreed to purchase its U.S. competitor in an effort to expand its product portfolio. Accelrys board agrees The French developer of computer […]

Merck & Co., Inc. (NYSE:MRK) Banks on New Drug amid Efforts to Stem Losses

Boston, MA 01/14/2013 (wallstreetpr) – Shares of Merck & Co., Inc. (NYSE:MRK) rose to 6.5 percent on Monday close regular session at $53.12 on news that the company started submitting  to Food and Drug Administration portions of completed application for its new cancer drug in an ongoing basis. This means that the drug could end […]

Sanofi SA (ADR) (NYSE:SNY) Loses Patent Protection

Boston, MA 10/22/2013 (wallstreetpr) – Sanofi SA (ADR) (NYSE:SNY) has been hit hard due to loss of patent protection in nine drugs in the last three years. The company is expecting a better fourth quarter. Increased competition from generic drugs is forcing such companies to invest heavily in R&D to develop new molecules. This is a […]